Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees.
Simon, Steven R. ; Andrade, Susan E. ; Ellis, Jennifer L. ; Nelson, Winnie W. ; Gurwitz, Jerry H. ; Lafata, Jennifer Elston ; Davis, Robert L. ; Feldstein, Adrianne ; Raebel, Marsha A.
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
Aged, 80 and over
Cardiovascular Agents
Cardiovascular Diseases
Comorbidity
Cross-Sectional Studies
Drug Monitoring
Female
Health Maintenance Organizations
Humans
Laboratory Techniques and Procedures
Logistic Models
Male
Medication Errors
Risk Factors
United States
Health Services Research
Medicine and Health Sciences
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
OBJECTIVES: To identify correlates of laboratory monitoring errors in elderly health maintenance organization (HMO) members at the initiation of therapy with cardiovascular medications.
DESIGN: Cross-sectional study in 10 HMOs.
SETTING: United States.
PARTICIPANTS: From a 2 million-member sample, individuals aged 65 and older who received one of seven cardiovascular medications (angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), amiodarone, digoxin, diuretics, potassium supplements, and statins) and did not have recommended baseline monitoring performed during the 180 days before or 14 days after the index dispensing.
MEASUREMENTS: The proportion of members receiving each drug for whom recommended laboratory monitoring was not performed. Laboratory monitoring error rates stratified by sex, age group, chronic disease score, and HMO site were examined, and logistic regression was used to identify predictors of laboratory monitoring errors.
RESULTS: Error rates varied by medication class, ranging from 23% of patients receiving potassium supplementation without serum potassium and serum creatinine monitoring to 58% of patients receiving amiodarone who did not have recommended monitoring for thyroid and liver function. Highest error rates occurred in the youngest elderly for ACE inhibitors, ARBs, digoxin, diuretics, and potassium supplements, although in patients receiving amiodarone and statins, errors were most frequent in the oldest elderly. Errors occurred more frequently in patients with less comorbidity.
CONCLUSION: Laboratory monitoring errors occurred frequently in elderly HMO members at the initiation of therapy with cardiovascular medications. Further study must examine the association between these errors and adverse outcomes.
Source
J Am Geriatr Soc. 2005 Dec;53(12):2165-9.